| Year |
Citation |
Score |
| 2015 |
Koudelka KJ, Pitek AS, Manchester M, Steinmetz NF. Virus-Based Nanoparticles as Versatile Nanomachines. Annual Review of Virology. 2: 379-401. PMID 26958921 DOI: 10.1146/Annurev-Virology-100114-055141 |
0.446 |
|
| 2014 |
Hovlid ML, Lau JL, Breitenkamp K, Higginson CJ, Laufer B, Manchester M, Finn MG. Encapsidated atom-transfer radical polymerization in Qβ virus-like nanoparticles. Acs Nano. 8: 8003-14. PMID 25073013 DOI: 10.1021/Nn502043D |
0.341 |
|
| 2013 |
Shriver LP, Plummer EM, Thomas DM, Ho S, Manchester M. Localization of gadolinium-loaded CPMV to sites of inflammation during central nervous system autoimmunity. Journal of Materials Chemistry. B. 1: 5256-5263. PMID 32263328 DOI: 10.1039/C3Tb20521E |
0.37 |
|
| 2013 |
Koudelka KJ, Ippoliti S, Medina E, Shriver LP, Trauger SA, Catalano CE, Manchester M. Lysine addressability and mammalian cell interactions of bacteriophage λ procapsids. Biomacromolecules. 14: 4169-76. PMID 24251756 DOI: 10.1021/Bm401577F |
0.437 |
|
| 2013 |
Plummer EM, Manchester M. Endocytic uptake pathways utilized by CPMV nanoparticles Molecular Pharmaceutics. 10: 26-32. PMID 22905759 DOI: 10.1021/Mp300238W |
0.415 |
|
| 2012 |
Hovlid ML, Steinmetz NF, Laufer B, Lau JL, Kuzelka J, Wang Q, Hyypiä T, Nemerow GR, Kessler H, Manchester M, Finn MG. Guiding plant virus particles to integrin-displaying cells. Nanoscale. 4: 3698-705. PMID 22585108 DOI: 10.1039/C2Nr30571B |
0.435 |
|
| 2012 |
Thomas D, Naughton J, Cote C, Welkos S, Manchester M, Young JA. Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment. Plos One. 7: e34611. PMID 22511955 DOI: 10.1371/Journal.Pone.0034611 |
0.315 |
|
| 2012 |
Plummer EM, Thomas D, Destito G, Shriver LP, Manchester M. Interaction of cowpea mosaic virus nanoparticles with surface vimentin and inflammatory cells in atherosclerotic lesions Nanomedicine. 7: 877-888. PMID 22394183 DOI: 10.2217/Nnm.11.185 |
0.386 |
|
| 2011 |
Venter PA, Dirksen A, Thomas D, Manchester M, Dawson PE, Schneemann A. Multivalent display of proteins on viral nanoparticles using molecular recognition and chemical ligation strategies. Biomacromolecules. 12: 2293-301. PMID 21545187 DOI: 10.1021/Bm200369E |
0.415 |
|
| 2011 |
Steinmetz NF, Cho CF, Ablack A, Lewis JD, Manchester M. Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells. Nanomedicine (London, England). 6: 351-64. PMID 21385137 DOI: 10.2217/Nnm.10.136 |
0.34 |
|
| 2011 |
Huang RK, Steinmetz NF, Fu CY, Manchester M, Johnson JE. Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells. Nanomedicine (London, England). 6: 55-68. PMID 21182418 DOI: 10.2217/Nnm.10.99 |
0.341 |
|
| 2011 |
Plummer EM, Manchester M. Viral nanoparticles and virus-like particles: Platforms for contemporary vaccine design Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 3: 174-196. PMID 20872839 DOI: 10.1002/Wnan.119 |
0.379 |
|
| 2010 |
Koudelka KJ, Manchester M. Chemically modified viruses: principles and applications. Current Opinion in Chemical Biology. 14: 810-7. PMID 21036656 DOI: 10.1016/J.Cbpa.2010.10.005 |
0.329 |
|
| 2010 |
Leong HS, Steinmetz NF, Ablack A, Destito G, Zijlstra A, Stuhlmann H, Manchester M, Lewis JD. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nature Protocols. 5: 1406-17. PMID 20671724 DOI: 10.1038/Nprot.2010.103 |
0.391 |
|
| 2010 |
Brunel FM, Lewis JD, Destito G, Steinmetz NF, Manchester M, Stuhlmann H, Dawson PE. Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Letters. 10: 1093-7. PMID 20163184 DOI: 10.1021/Nl1002526 |
0.392 |
|
| 2010 |
Steinmetz NF, Mertens ME, Taurog RE, Johnson JE, Commandeur U, Fischer R, Manchester M. Potato virus X as a novel platform for potential biomedical applications. Nano Letters. 10: 305-12. PMID 20017489 DOI: 10.1021/Nl9035753 |
0.426 |
|
| 2009 |
Gonzalez MJ, Plummer EM, Rae CS, Manchester M. Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo Plos One. 4. PMID 19956734 DOI: 10.1371/Journal.Pone.0007981 |
0.441 |
|
| 2009 |
Steinmetz NF, Hong V, Spoerke ED, Lu P, Breitenkamp K, Finn MG, Manchester M. Buckyballs meet viral nanoparticles: candidates for biomedicine. Journal of the American Chemical Society. 131: 17093-5. PMID 19904938 DOI: 10.1021/Ja902293W |
0.353 |
|
| 2009 |
Wikoff WR, Kalisak E, Trauger S, Manchester M, Siuzdak G. Response and recovery in the plasma metabolome tracks the acute LCMV-induced immune response. Journal of Proteome Research. 8: 3578-87. PMID 19496611 DOI: 10.1021/Pr900275P |
0.305 |
|
| 2009 |
Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, Manchester M. Endothelial targeting of cowpea mosaic virus (CPMV) via surface vimentin Plos Pathogens. 5. PMID 19412526 DOI: 10.1371/Journal.Ppat.1000417 |
0.377 |
|
| 2009 |
Shriver LP, Koudelka KJ, Manchester M. Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection. Journal of Neuroimmunology. 211: 66-72. PMID 19394707 DOI: 10.1016/J.Jneuroim.2009.03.015 |
0.405 |
|
| 2009 |
Kumar S, Ochoa W, Singh P, Hsu C, Schneemann A, Manchester M, Olson M, Reddy V. Tomato bushy stunt virus (TBSV), a versatile platform for polyvalent display of antigenic epitopes and vaccine design. Virology. 388: 185-90. PMID 19344926 DOI: 10.1016/J.Virol.2009.02.051 |
0.449 |
|
| 2009 |
Steinmetz NF, Manchester M. PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo. Biomacromolecules. 10: 784-92. PMID 19281149 DOI: 10.1021/Bm8012742 |
0.387 |
|
| 2009 |
Destito G, Schneemann A, Manchester M. Biomedical nanotechnology using virus-based nanoparticles Current Topics in Microbiology and Immunology. 327: 95-122. PMID 19198572 DOI: 10.1007/978-3-540-69379-6_5 |
0.425 |
|
| 2009 |
Portney NG, Destito G, Manchester M, Ozkan M. Hybrid assembly of CPMV viruses and surface characteristics of different mutants Current Topics in Microbiology and Immunology. 327: 59-69. PMID 19198570 DOI: 10.1007/978-3-540-69379-6_3 |
0.405 |
|
| 2008 |
Rae C, Koudelka KJ, Destito G, Estrada MN, Gonzalez MJ, Manchester M. Chemical addressability of ultraviolet-inactivated viral nanoparticles (VNPs). Plos One. 3: e3315. PMID 18830402 DOI: 10.1371/Journal.Pone.0003315 |
0.457 |
|
| 2008 |
Prasuhn DE, Singh P, Strable E, Brown S, Manchester M, Finn MG. Plasma clearance of bacteriophage Qbeta particles as a function of surface charge. Journal of the American Chemical Society. 130: 1328-34. PMID 18177041 DOI: 10.1021/Ja075937F |
0.322 |
|
| 2008 |
Martinez-Morales AA, Portney NG, Zhang Y, Destito G, Budak G, Ozbay E, Manchester M, Ozkan CS, Ozkan M. Synthesis and characterization of iron oxide derivatized mutant cowpea mosaic virus hybrid nanoparticles Advanced Materials. 20: 4816-4820. DOI: 10.1002/Adma.200702863 |
0.312 |
|
| 2008 |
Steinmetz NF, Bize A, Findlay KC, Lomonossoff GP, Manchester M, Evans DJ, Prangishvili D. Site-specific and spatially controlled addressability of a new viral nanobuilding block: Sulfolobus islandicus rod-shaped virus 2 Advanced Functional Materials. 18: 3478-3486. DOI: 10.1002/Adfm.200800711 |
0.409 |
|
| 2007 |
Destito G, Yeh R, Rae CS, Finn MG, Manchester M. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chemistry & Biology. 14: 1152-62. PMID 17961827 DOI: 10.1016/J.Nano.2007.10.060 |
0.399 |
|
| 2007 |
Manayani DJ, Thomas D, Dryden KA, Reddy V, Siladi ME, Marlett JM, Rainey GJ, Pique ME, Scobie HM, Yeager M, Young JA, Manchester M, Schneemann A. A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. Plos Pathogens. 3: 1422-31. PMID 17922572 DOI: 10.1371/Journal.Ppat.0030142 |
0.419 |
|
| 2007 |
Singh P, Prasuhn D, Yeh RM, Destito G, Rae CS, Osborn K, Finn MG, Manchester M. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 120: 41-50. PMID 17512998 DOI: 10.1016/J.Jconrel.2007.04.003 |
0.419 |
|
| 2007 |
Prasuhn DE, Yeh RM, Obenaus A, Manchester M, Finn MG. Viral MRI contrast agents: coordination of Gd by native virions and attachment of Gd complexes by azide-alkyne cycloaddition. Chemical Communications (Cambridge, England). 1269-71. PMID 17356779 DOI: 10.1039/B615084E |
0.332 |
|
| 2007 |
Koudelka KJ, Rae CS, Gonzalez MJ, Manchester M. Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus. Journal of Virology. 81: 1632-40. PMID 17121801 DOI: 10.1128/Jvi.00960-06 |
0.42 |
|
| 2007 |
Koudelka KJ, Rae C, Manchester M. A Plant-Virus Based Nanoscaffold Interacts Specifically with the Mammalian Cell Surface Nanomedicine: Nanotechnology, Biology and Medicine. 3: 349-350. DOI: 10.1016/J.Nano.2007.10.062 |
0.38 |
|
| 2006 |
Manchester M, Singh P. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. Advanced Drug Delivery Reviews. 58: 1505-22. PMID 17118484 DOI: 10.1016/J.Addr.2006.09.014 |
0.369 |
|
| 2006 |
Lewis JD, Destito G, Zijlstra A, Gonzalez MJ, Quigley JP, Manchester M, Stuhlmann H. Viral nanoparticles as tools for intravital vascular imaging. Nature Medicine. 12: 354-60. PMID 16501571 DOI: 10.1038/Nm1368 |
0.345 |
|
| 2006 |
Singh P, Destito G, Schneemann A, Manchester M. Canine parvovirus-like particles, a novel nanomaterial for tumor targeting. Journal of Nanobiotechnology. 4: 2. PMID 16476163 DOI: 10.1186/1477-3155-4-2 |
0.366 |
|
| 2006 |
Manchester M. Targeted therapy using virus-based nanoparticles (VNPs) Nanomedicine: Nanotechnology, Biology and Medicine. 2: 294. DOI: 10.1016/J.Nano.2006.10.081 |
0.371 |
|
| 2006 |
Singh P, Gonzalez MJ, Manchester M. Viruses and their uses in nanotechnology Drug Development Research. 67: 23-41. DOI: 10.1002/Ddr.20064 |
0.303 |
|
| 2005 |
Sen Gupta S, Kuzelka J, Singh P, Lewis WG, Manchester M, Finn MG. Accelerated bioorthogonal conjugation: a practical method for the ligation of diverse functional molecules to a polyvalent virus scaffold. Bioconjugate Chemistry. 16: 1572-9. PMID 16287257 DOI: 10.1021/Bc050147L |
0.325 |
|
| 2005 |
Rae CS, Khor IW, Wang Q, Destito G, Gonzalez MJ, Singh P, Thomas DM, Estrada MN, Powell E, Finn MG, Manchester M. Systemic trafficking of plant virus nanoparticles in mice via the oral route. Virology. 343: 224-35. PMID 16185741 DOI: 10.1016/J.Virol.2005.08.017 |
0.706 |
|
| 2005 |
Portney NG, Singh K, Chaudhary S, Destito G, Schneemann A, Manchester M, Ozkan M. Organic and inorganic nanoparticle hybrids. Langmuir : the Acs Journal of Surfaces and Colloids. 21: 2098-103. PMID 15751992 DOI: 10.1021/La047525F |
0.333 |
|
| 2004 |
Naniche D, Garenne M, Rae C, Manchester M, Buchta R, Brodine SK, Oldstone MB. Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. The Journal of Infectious Diseases. 190: 1387-95. PMID 15378430 DOI: 10.1086/424571 |
0.325 |
|
| 2003 |
Raja KS, Wang Q, Gonzalez MJ, Manchester M, Johnson JE, Finn MG. Hybrid virus-polymer materials. 1. Synthesis and properties of PEG-decorated cowpea mosaic virus Biomacromolecules. 4: 472-476. PMID 12741758 DOI: 10.1021/Bm025740+ |
0.362 |
|
| 2003 |
Hahm B, Arbour N, Naniche D, Homann D, Manchester M, Oldstone MB. Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule. Journal of Virology. 77: 3505-15. PMID 12610126 DOI: 10.1128/Jvi.77.6.3505-3515.2003 |
0.383 |
|
| 2002 |
Manchester M, Smith KA, Eto DS, Perkin HB, Torbett BE. Targeting and hematopoietic suppression of human CD34+ cells by measles virus. Journal of Virology. 76: 6636-42. PMID 12050376 DOI: 10.1128/Jvi.76.13.6636-6642.2002 |
0.394 |
|
| 2002 |
Khor IW, Lin T, Langedijk JP, Johnson JE, Manchester M. Novel strategy for inhibiting viral entry by use of a cellular receptor-plant virus chimera. Journal of Virology. 76: 4412-9. PMID 11932408 DOI: 10.1128/Jvi.76.9.4412-4419.2002 |
0.7 |
|
| 2001 |
Patterson JB, Manchester M, Oldstone MB. Disease model: dissecting the pathogenesis of the measles virus. Trends in Molecular Medicine. 7: 85-8. PMID 11286761 DOI: 10.1016/S1471-4914(01)01918-9 |
0.385 |
|
| 2001 |
Manchester M, Rall GR. Model Systems: Transgenic mouse models for measles pathogenesis Trends in Microbiology. 9: 19-23. PMID 11166238 DOI: 10.1016/S0966-842X(00)01903-X |
0.362 |
|
| 2000 |
Liszewski MK, Leung M, Cui W, Subramanian VB, Parkinson J, Barlow PN, Manchester M, Atkinson JP. Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46) Journal of Biological Chemistry. 275: 37692-37701. PMID 10960475 DOI: 10.1074/Jbc.M004650200 |
0.315 |
|
| 2000 |
Manchester M, Naniche D, Stehlet T. CD46 as a measles receptor: Form follows function Virology. 274: 5-10. PMID 10936082 DOI: 10.1006/Viro.2000.0469 |
0.356 |
|
| 2000 |
Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MB. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of Alpha/Beta interferon production. Journal of Virology. 74: 7478-84. PMID 10906201 DOI: 10.1128/Jvi.74.16.7478-7484.2000 |
0.339 |
|
| 2000 |
Manchester M, Eto DS, Valsamakis A, Liton PB, Fernandez-Muñoz R, Rota PA, Bellini WJ, Forthal DN, Oldstone MB. Clinical isolates of measles virus use CD46 as a cellular receptor. Journal of Virology. 74: 3967-74. PMID 10756008 DOI: 10.1128/Jvi.74.9.3967-3974.2000 |
0.342 |
|
| 1999 |
Oldstone MB, Lewicki H, Thomas D, Tishon A, Dales S, Patterson J, Manchester M, Homann D, Naniche D, Holz A. Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell. 98: 629-40. PMID 10490102 DOI: 10.1016/S0092-8674(00)80050-1 |
0.323 |
|
| 1999 |
Manchester M, Eto DS, Oldstone MB. Characterization of the inflammatory response during acute measles encephalitis in NSE-CD46 transgenic mice. Journal of Neuroimmunology. 96: 207-17. PMID 10337919 DOI: 10.1016/S0165-5728(99)00036-3 |
0.381 |
|
| 1999 |
Patterson JB, Scheiflinger F, Manchester M, Yilma T, Oldstone MB. Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction. Virology. 256: 142-51. PMID 10087234 DOI: 10.1006/Viro.1999.9644 |
0.399 |
|
| 1997 |
Manchester M, Gairin JE, Patterson JB, Alvarez J, Liszewski MK, Eto DS, Atkinson JP, Oldstone MB. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. Virology. 233: 174-84. PMID 9201227 DOI: 10.1006/Viro.1997.8581 |
0.377 |
|
| 1997 |
Rall GF, Manchester M, Daniels LR, Callahan EM, Belman AR, Oldstone MB. A transgenic mouse model for measles virus infection of the brain. Proceedings of the National Academy of Sciences of the United States of America. 94: 4659-63. PMID 9114047 DOI: 10.1073/Pnas.94.9.4659 |
0.368 |
|
| 1996 |
Tishon A, Manchester M, Scheiflinger F, Oldstone MB. A model of measles virus-induced immunosuppression: enhanced susceptibility of neonatal human PBLs. Nature Medicine. 2: 1250-4. PMID 8898755 DOI: 10.1038/Nm1196-1250 |
0.388 |
|
| 1995 |
Manchester M, Valsamakis A, Kaufman R, Liszewski MK, Alvarez J, Atkinson JP, Lublin DM, Oldstone MB. Measles virus and C3 binding sites are distinct on membrane cofactor protein (CD46). Proceedings of the National Academy of Sciences of the United States of America. 92: 2303-7. PMID 7534417 DOI: 10.1073/Pnas.92.6.2303 |
0.356 |
|
| 1994 |
Manchester M, Liszewski MK, Atkinson JP, Oldstone MB. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proceedings of the National Academy of Sciences of the United States of America. 91: 2161-5. PMID 8134365 DOI: 10.1073/Pnas.91.6.2161 |
0.388 |
|
| Show low-probability matches. |